Sign in to view content

Phentolamine Ophthalmic Solution Rapidly Reverses Pharmacologically Induced Mydriasis in Two Pivotal Phase 3 MIRA Trials

David S. Boyer, MD

Video
Published 2022

Related

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024
Surgical Case Conference: Stephanie Hsu, MD
Stephanie Tammy Hsu
Annual Meeting Talks
2024
Silicone Oil (SO) Microdroplets in Repackaged Bevacizumab Syringes: Identification, Quantification, and Strategies For Reducing Clincal Impact
John D Pitcher, MD
On Demand Cases, Courses, and Papers
2017

Category: Pharmacology

See more